Access Statistics for Bhaven N. Sampat

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Survey of Empirical Evidence on Patents and Innovation 1 1 1 78 2 4 38 179
America, Jump-started: World War II R&D and the Takeoff of the U.S. Innovation System 0 0 3 92 0 3 43 263
Applicant and Examiner Citations in US Patents: An Overview and Analysis 0 0 1 60 3 8 25 209
Crisis Innovation Policy from World War II to COVID-19 0 0 0 40 1 1 12 63
Drug patenting in India: looking back andlooking forward 0 0 0 16 2 2 6 32
How Do Patents Affect Follow-On Innovation? Evidence from the Human Genome 0 0 1 63 1 3 28 202
In-Text Patent Citations: A User’s Guide 0 0 0 27 3 3 13 76
Indirect Cost Recovery in U.S. Innovation Policy: History, Evidence, and Avenues for Reform 0 0 1 12 1 4 23 46
Innovation, technical change and patents in the development process: A long term view 0 0 1 469 1 2 16 751
Intellectual property rights and pharmaceuticals: The case of antibiotics 0 1 2 123 0 3 29 487
Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules 0 1 2 39 5 10 34 174
Retreating from Science: The Long-Run Effects of the 1970s U.S. Military Disinvestment from University Research 0 2 2 2 57 60 60 60
Secondary Pharmaceutical Patenting: A Global Perspective 0 0 1 28 1 1 11 124
The Diffusion of Scientific Knowledge Across Time and Space: Evidence from Professional Transitions for the Superstars of Medicine 0 1 1 37 0 2 18 227
The Dynamics of Inattention in the (Baseball) Field 0 0 0 8 1 1 18 53
The Economics of Crisis Innovation Policy: A Historical Perspective 0 0 0 71 2 2 16 132
The Feasibility of Using Bayh-Dole March-In Rights to Lower Drug Prices: An Update 0 0 0 1 3 4 11 19
The Government Patent Register: A New Resource for Measuring U.S. Government-Funded Patenting 0 0 0 31 2 3 25 80
The NBER Orange Book Dataset: A User’s Guide 0 0 0 23 1 2 20 55
The Therapeutic Consequences of the War: World War II and the 20th-Century Expansion of Biomedicine 0 0 4 22 2 4 25 45
The World War II Crisis Innovation Model: What Was It, and Where Does It Apply? 0 0 0 49 1 1 17 77
Total Working Papers 1 6 20 1,291 89 123 488 3,354


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A.N. Link and D.S. Siegel, Technological Change and Economic Performance, Routledge (2003) (176 pp., [Ukpound] 65.00, ISBN 0415 271398) 0 0 0 25 1 1 3 130
Academic patents and access to medicines in developing countries 0 0 0 5 1 1 8 26
Applicant and examiner citations in U.S. patents: An overview and analysis 0 0 2 80 3 11 48 416
Can Private Money Buy Public Science? Disease Group Lobbying and Federal Funding for Biomedical Research 0 0 3 15 1 4 29 76
Changes in university patent quality after the Bayh-Dole act: a re-examination 0 1 3 88 1 6 32 343
Corporate funding for schools of public health: Confronting the ethical and economic challenges 0 0 0 2 1 1 3 13
Do applicant patent citations matter? 0 0 0 36 3 6 14 176
Evergreening, patent challenges, and effective market life in pharmaceuticals 1 4 7 208 3 9 45 608
Examiner Characteristics and Patent Office Outcomes 0 1 5 97 1 10 25 302
Examiner citations, applicant citations, and the private value of patents 0 0 2 87 0 1 11 251
How Do Patents Affect Follow-On Innovation? Evidence from the Human Genome 0 0 1 45 0 6 26 372
How Do University Inventions Get Into Practice? 0 0 0 78 1 4 28 284
Las instituciones como factor que regula el desempeño económico 0 0 0 299 0 0 12 743
Learning to Patent: Institutional Experience, Learning, and the Characteristics of U.S. University Patents After the Bayh-Dole Act, 1981-1992 0 0 0 11 0 2 18 79
Making sense of institutions as a factor shaping economic performance 0 0 3 626 2 4 30 1,390
Mission-oriented biomedical research at the NIH 0 1 7 98 1 5 33 282
Patenting and Licensing University Inventions: Lessons from the History of the Research Corporation 0 0 0 0 2 3 10 363
Patenting and US academic research in the 20th century: The world before and after Bayh-Dole 0 1 3 212 0 2 25 560
Secondary pharmaceutical patenting: A global perspective 2 2 3 16 4 6 30 95
The Bayh-Dole Act of 1980 and University--Industry Technology Transfer: A Model for Other OECD Governments? 0 1 6 222 0 5 24 645
The growth of patenting and licensing by U.S. universities: an assessment of the effects of the Bayh-Dole act of 1980 1 9 40 567 3 30 161 1,379
University Patents and Patent Policy Debates in the USA, 1925-1980 0 0 0 0 0 2 12 557
University patenting: an assessment of the causes and consequences of recent changes in strategies and practices 0 0 0 15 0 0 6 69
When Do Applicants Search for Prior Art? 1 1 4 116 1 6 27 290
Why and how innovations get adopted: a tale of four models 0 0 0 4 1 2 15 748
Total Journal Articles 5 21 89 2,952 30 127 675 10,197


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Comment on "Local Effects of Land Grant Colleges on Agricultural Innovation and Output" 0 0 0 0 0 0 3 16
Crisis Innovation Policy from World War II to COVID-19 0 0 1 12 0 1 18 63
Indirect Cost Recovery in US Innovation Policy: History, Evidence, and Avenues for Reform 0 0 0 1 0 1 19 22
Taking Stock: The Past and Future of Biomedical Research Funding 0 0 0 0 1 2 12 12
The Diffusion of Scientific Knowledge across Time and Space: Evidence from Professional Transitions for the Superstars of Medicine 0 0 3 41 1 3 28 225
The Dismal Science, the Crown Jewel and the Endless Frontier 0 0 0 9 0 0 5 33
Weak Patents Are a Weak Deterrent: Patent Portfolios, the Orange Book Listing Standard, and Generic Entry in Pharmaceuticals 0 0 0 11 1 1 15 131
Total Chapters 0 0 4 74 3 8 100 502


Statistics updated 2026-09-10